JBHT
70
2
COST
63
-4
AA
57
-6
ROP
62
-3
SYK
66
2
AON
60
-2
UNM
79
2
ICE
62
3
DE
40
4
TXN
55
-4
MCHP
41
-4
AAP
39
7
EW
29
2
EL
18
3
CF
53
5
FOX
53
2
JNPR
54
-2
HSY
35
3
DAL
85
2
ADBE
49
3
JBHT
70
2
COST
63
-4
AA
57
-6
ROP
62
-3
SYK
66
2
AON
60
-2
UNM
79
2
ICE
62
3
DE
40
4
TXN
55
-4
MCHP
41
-4
AAP
39
7
EW
29
2
EL
18
3
CF
53
5
FOX
53
2
JNPR
54
-2
HSY
35
3
DAL
85
2
ADBE
49
3
Financhill
Back

Novo Nordisk AS Vs. Ascendis Pharma AS Industry Stock Comparison

Sell
39

NVO
Novo Nordisk AS

Last Price:
107.09
Seasonality Move:
9.3%
Sell
32

ASND
Ascendis Pharma AS

Last Price:
127.58
Seasonality Move:
11.25%
Sell
39
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $109.09. The Score for NVO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS a Buy, Sell or Hold?

  • The current Ascendis Pharma AS [ASND] share price is $128.69. The Score for ASND is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $109.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.

ASND Stock Price Chart

What is Ascendis Pharma AS's stock price today?

  • The Ascendis Pharma AS share price today is $128.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.7 Sell
Relative Strength Index (14 RSI): 36.25 Sell
Chaikin Money Flow: -3992643 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (109.94 - 118.12) Sell
Bollinger Bands (100): (117.81 - 139.27) Sell

ASND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.08 Sell
Relative Strength Index (14 RSI): 48.94 Sell
Chaikin Money Flow: 175350 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (125.25 - 131.61) Buy
Bollinger Bands (100): (125.14 - 141.84) Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 109.13 Sell
20-day SMA: 113.06 Sell
50-day SMA: 121.23 Sell
200-day SMA: 128.28 Sell
8-day EMA: 109.23 Sell
20-day EMA: 112.5 Sell
50-day EMA: 118.99 Sell
200-day EMA: 122.09 Sell

ASND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 126.35 Buy
20-day SMA: 127.55 Buy
50-day SMA: 132.29 Sell
200-day SMA: 137.29 Sell
8-day EMA: 126.95 Buy
20-day EMA: 128.49 Buy
50-day EMA: 131.42 Sell
200-day EMA: 130.7 Sell

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and an increase next year of $0.69 per share.

Ascendis Pharma AS Earnings Growth & ASND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.70 per share, and an increase next year of $4.28 per share.

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ascendis Pharma AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):